256 related articles for article (PubMed ID: 32845968)
41. Alcohol Intake and Weight Loss During Intensive Lifestyle Intervention for Adults with Overweight or Obesity and Diabetes.
Chao AM; Wadden TA; Tronieri JS; Berkowitz RI
Obesity (Silver Spring); 2019 Jan; 27(1):30-40. PubMed ID: 30421851
[TBL] [Abstract][Full Text] [Related]
42. The Effect of Intentional Weight Loss on Fracture Risk in Persons With Diabetes: Results From the Look AHEAD Randomized Clinical Trial.
Johnson KC; Bray GA; Cheskin LJ; Clark JM; Egan CM; Foreyt JP; Garcia KR; Glasser S; Greenway FL; Gregg EW; Hazuda HP; Hergenroeder A; Hill JO; Horton ES; Jakicic JM; Jeffery RW; Kahn SE; Knowler WC; Lewis CE; Miller M; Montez MG; Nathan DM; Patricio JL; Peters AL; Pi-Sunyer X; Pownall HJ; Reboussin D; Redmon JB; Steinberg H; Wadden TA; Wagenknecht LE; Wing RR; Womack CR; Yanovski SZ; Zhang P; Schwartz AV;
J Bone Miner Res; 2017 Nov; 32(11):2278-2287. PubMed ID: 28678345
[TBL] [Abstract][Full Text] [Related]
43. Association of Weight Loss Maintenance and Weight Regain on 4-Year Changes in CVD Risk Factors: the Action for Health in Diabetes (Look AHEAD) Clinical Trial.
Wing RR; Espeland MA; Clark JM; Hazuda HP; Knowler WC; Pownall HJ; Unick J; Wadden T; Wagenknecht L;
Diabetes Care; 2016 Aug; 39(8):1345-55. PubMed ID: 27271190
[TBL] [Abstract][Full Text] [Related]
44. The effects of an exercise and lifestyle intervention program on cardiovascular, metabolic factors and cognitive performance in middle-aged adults with type II diabetes: a pilot study.
Fiocco AJ; Scarcello S; Marzolini S; Chan A; Oh P; Proulx G; Greenwood C
Can J Diabetes; 2013 Aug; 37(4):214-219. PubMed ID: 24070883
[TBL] [Abstract][Full Text] [Related]
45. Long-term impact of behavioral weight loss intervention on cognitive function.
Espeland MA; Rapp SR; Bray GA; Houston DK; Johnson KC; Kitabchi AE; Hergenroeder AL; Williamson J; Jakicic JM; van Dorsten B; Kritchevsky SB; ;
J Gerontol A Biol Sci Med Sci; 2014 Sep; 69(9):1101-8. PubMed ID: 24619151
[TBL] [Abstract][Full Text] [Related]
46. Severe hypoglycemia in the Look AHEAD Trial.
; Greenway FL
J Diabetes Complications; 2016 Jul; 30(5):935-43. PubMed ID: 27114389
[TBL] [Abstract][Full Text] [Related]
47. Long-term impact of intensive lifestyle intervention on cognitive function assessed with the National Institutes of Health Toolbox: The Look AHEAD study.
Hayden KM; Baker LD; Bray G; Carvajal R; Demos-McDermott K; Hergenroeder AL; Hill JO; Horton E; Jakicic JM; Johnson KC; Neiberg RH; Rapp SR; Wadden TA; Miller ME
Alzheimers Dement (Amst); 2018; 10():41-48. PubMed ID: 29159267
[TBL] [Abstract][Full Text] [Related]
48. Changes in skeletal muscle and organ size after a weight-loss intervention in overweight and obese type 2 diabetic patients.
Gallagher D; Kelley DE; Thornton J; Boxt L; Pi-Sunyer X; Lipkin E; Nyenwe E; Janumala I; Heshka S;
Am J Clin Nutr; 2017 Jan; 105(1):78-84. PubMed ID: 27881389
[TBL] [Abstract][Full Text] [Related]
49. Association of depression with accelerated cognitive decline among patients with type 2 diabetes in the ACCORD-MIND trial.
Sullivan MD; Katon WJ; Lovato LC; Miller ME; Murray AM; Horowitz KR; Bryan RN; Gerstein HC; Marcovina S; Akpunonu BE; Johnson J; Yale JF; Williamson J; Launer LJ
JAMA Psychiatry; 2013 Oct; 70(10):1041-7. PubMed ID: 23945905
[TBL] [Abstract][Full Text] [Related]
50. Lifestyle intervention and/or statins for the reduction of C-reactive protein in type 2 diabetes: from the look AHEAD study.
Belalcazar LM; Haffner SM; Lang W; Hoogeveen RC; Rushing J; Schwenke DC; Tracy RP; Pi-Sunyer FX; Kriska AM; Ballantyne CM;
Obesity (Silver Spring); 2013 May; 21(5):944-50. PubMed ID: 23512860
[TBL] [Abstract][Full Text] [Related]
51. Metabolic factors, adipose tissue, and plasminogen activator inhibitor-1 levels in type 2 diabetes: findings from the look AHEAD study.
Belalcazar LM; Ballantyne CM; Lang W; Haffner SM; Rushing J; Schwenke DC; Pi-Sunyer FX; Tracy RP;
Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1689-95. PubMed ID: 21512162
[TBL] [Abstract][Full Text] [Related]
52. Effects of weight loss intervention on erectile function in older men with type 2 diabetes in the Look AHEAD trial.
Wing RR; Rosen RC; Fava JL; Bahnson J; Brancati F; Gendrano Iii IN; Kitabchi A; Schneider SH; Wadden TA
J Sex Med; 2010 Jan; 7(1 Pt 1):156-65. PubMed ID: 19694925
[TBL] [Abstract][Full Text] [Related]
53. Lifestyle Intervention for Weight Loss and Cardiometabolic Changes in the Setting of Glucokinase Regulatory Protein Inhibition: Glucokinase Regulatory Protein-Leu446Pro Variant in Look AHEAD.
Belalcazar LM; Papandonatos GD; Erar B; Peter I; Alkofide H; Balasubramanyam A; Brautbar A; Kahn SE; Knowler WC; Ballantyne CM; McCaffery JM; Huggins GS;
Circ Cardiovasc Genet; 2016 Feb; 9(1):71-8. PubMed ID: 26578543
[TBL] [Abstract][Full Text] [Related]
54. Long-term effect of weight loss on obstructive sleep apnea severity in obese patients with type 2 diabetes.
Kuna ST; Reboussin DM; Borradaile KE; Sanders MH; Millman RP; Zammit G; Newman AB; Wadden TA; Jakicic JM; Wing RR; Pi-Sunyer FX; Foster GD;
Sleep; 2013 May; 36(5):641-649A. PubMed ID: 23633746
[TBL] [Abstract][Full Text] [Related]
55. Design and participant characteristics of a primary care adaptation of the Look AHEAD Lifestyle Intervention for weight loss in type 2 diabetes: The REAL HEALTH-diabetes study.
Delahanty LM; Chang Y; Levy DE; Porneala B; Dushkin A; Bissett L; Goldman V; Perrotta J; Rodriguez AR; Chase B; LaRocca R; Wheeler A; Wexler DJ
Contemp Clin Trials; 2018 Aug; 71():9-17. PubMed ID: 29803816
[TBL] [Abstract][Full Text] [Related]
56. Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes.
Ryan DH; Espeland MA; Foster GD; Haffner SM; Hubbard VS; Johnson KC; Kahn SE; Knowler WC; Yanovski SZ;
Control Clin Trials; 2003 Oct; 24(5):610-28. PubMed ID: 14500058
[TBL] [Abstract][Full Text] [Related]
57. Relative differences in resting-state brain connectivity associated with long term intensive lifestyle intervention.
Casanova R; Hayasaka S; Saldana S; Bryan NR; Demos KE; Desiderio L; Erickson KI; Espeland MA; Nasrallah IM; Wadden T; Laurienti PJ;
Psychoneuroendocrinology; 2016 Dec; 74():231-239. PubMed ID: 27685338
[TBL] [Abstract][Full Text] [Related]
58. Effect of the look AHEAD study intervention on medication use and related cost to treat cardiovascular disease risk factors in individuals with type 2 diabetes.
Redmon JB; Bertoni AG; Connelly S; Feeney PA; Glasser SP; Glick H; Greenway F; Hesson LA; Lawlor MS; Montez M; Montgomery B;
Diabetes Care; 2010 Jun; 33(6):1153-8. PubMed ID: 20332353
[TBL] [Abstract][Full Text] [Related]
59. The cross-sectional and longitudinal associations of diabetic retinopathy with cognitive function and brain MRI findings: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.
Hugenschmidt CE; Lovato JF; Ambrosius WT; Bryan RN; Gerstein HC; Horowitz KR; Launer LJ; Lazar RM; Murray AM; Chew EY; Danis RP; Williamson JD; Miller ME; Ding J
Diabetes Care; 2014 Dec; 37(12):3244-52. PubMed ID: 25193529
[TBL] [Abstract][Full Text] [Related]
60. Legacy of a 10-Year Multidomain Lifestyle Intervention on the Cognitive Trajectories of Individuals with Overweight/Obesity and Type 2 Diabetes Mellitus.
Hayden KM; Neiberg RH; Evans JK; Luchsinger JA; Carmichael O; Dutton GR; Johnson KC; Kahn SE; Rapp SR; Yasar S; Espeland MA;
Dement Geriatr Cogn Disord; 2021; 50(3):237-249. PubMed ID: 34412057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
